Analyst Consensus ?
ConsensusBuy33 ratings
Bullish1854.5%
Neutral1545.5%
Bearish00.0%
FN2 Earnings Intelligence
Cardinal Health, Inc. analyst ratings
Cardinal Health, Inc. (CAH) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$234.57Current
$53Low
$192.16Average
$292High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Sep 13, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Aug 13, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 13, 2026 |
| Barclays | Overweight | Overweight | Maintain | Aug 13, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Aug 12, 2026 |
| UBS | Buy | Buy | Maintain | Aug 12, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Aug 12, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Aug 12, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Aug 12, 2026 |
| Citigroup | Buy | Buy | Maintain | Aug 12, 2026 |
| Baird | Outperform | Outperform | Maintain | Aug 12, 2026 |
| B of A Securities | Buy | Buy | Maintain | Jul 2, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Aug 12, 2025 |
| Jefferies | Buy | Hold | Upgrade | Feb 5, 2025 |
| Deutsche Bank | Hold | Hold | Maintain | Nov 4, 2024 |
| Argus Research | Buy | Buy | Maintain | Sep 11, 2024 |
| Credit Suisse | Neutral | Neutral | Maintain | Jun 12, 2023 |
| Cowen & Co. | Market Perform | Market Perform | Maintain | Aug 16, 2022 |
| CFRA | Hold | Hold | Maintain | May 11, 2020 |
| Guggenheim | Neutral | Buy | Downgrade | Dec 16, 2019 |
| Argus | Hold | Buy | Downgrade | Aug 27, 2019 |
| Leerink Swann | Market Perform | Outperform | Downgrade | Nov 16, 2018 |
| RBC Capital | Perform | Sector Perform | Maintain | Sep 19, 2017 |
| Tigress Financial | Neutral | Neutral | Maintain | Apr 28, 2017 |
| William Blair | Market Perform | Outperform | Downgrade | Apr 19, 2017 |
| Needham | Hold | Hold | Maintain | Apr 4, 2017 |
| Goldman Sachs | Neutral | Buy | Downgrade | Sep 16, 2016 |
| Avondale Partners | Outperform | Market Outperform | Maintain | Apr 18, 2016 |
| Raymond James | Market Perform | Outperform | Downgrade | Jan 6, 2016 |
| FBR Capital | Outperform | Outperform | Maintain | Mar 10, 2015 |
| Bank of America | Buy | Buy | Maintain | Dec 29, 2014 |
| Sterne Agee | Buy | Neutral | Upgrade | Nov 6, 2013 |
| ISI Group | Buy | Strong Buy | Downgrade | Mar 20, 2013 |
| Lazard | Neutral | Buy | Downgrade | Mar 19, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $234.57. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Ryan Halsted | $276 | $234.98 | +17.7% | Aug 19, 2026 |
| Barclays | Analyst unavailable | $275 | $234.16 | +17.2% | Aug 13, 2026 |
| Morgan Stanley | Analyst unavailable | $265 | $236.64 | +13.0% | Aug 12, 2026 |
| Evercore ISI | Analyst unavailable | $270 | $240.26 | +15.1% | Aug 12, 2026 |
| UBS | Analyst unavailable | $280 | $240.26 | +19.4% | Aug 12, 2026 |
| Wells Fargo | Stephen Baxter | $277 | $240.26 | +18.1% | Aug 12, 2026 |
| Mizuho Securities | Steven Valiquette | $250 | $240.26 | +6.6% | Aug 12, 2026 |
| Robert W. Baird | Eric Coldwell | $274 | $240.26 | +16.8% | Aug 12, 2026 |
| Leerink Partners | Analyst unavailable | $292 | $240.26 | +24.5% | Aug 11, 2026 |
| UBS | Analyst unavailable | $274 | $226.42 | +16.8% | Jul 20, 2026 |
| Robert W. Baird | Analyst unavailable | $248 | $195.08 | +5.7% | May 1, 2026 |
| Evercore ISI | Elizabeth Anderson | $240 | $215.13 | +2.3% | Apr 8, 2026 |
| Leerink Partners | Michael Cherny | $275 | $222.28 | +17.2% | Mar 9, 2026 |
| Barclays | Analyst unavailable | $258 | $224.82 | +10.0% | Feb 24, 2026 |
| Wells Fargo | Analyst unavailable | $256 | $225.76 | +9.1% | Feb 10, 2026 |
| Morgan Stanley | Analyst unavailable | $255 | $229.63 | +8.7% | Feb 6, 2026 |
| Robert W. Baird | Analyst unavailable | $252 | $228.78 | +7.4% | Feb 6, 2026 |
| UBS | Kevin Caliendo | $260 | $228.63 | +10.8% | Feb 6, 2026 |
| Mizuho Securities | Steven Valiquette | $235 | $227.18 | +0.2% | Feb 6, 2026 |
| Evercore ISI | Elizabeth Anderson | $260 | $227.18 | +10.8% | Feb 5, 2026 |
| Morgan Stanley | Erin Wright | $245 | $210.39 | +4.4% | Jan 29, 2026 |
| Robert W. Baird | Eric Coldwell | $250 | $211.98 | +6.6% | Jan 14, 2026 |
| Leerink Partners | Michael Cherny | $240 | $208.24 | +2.3% | Jan 13, 2026 |
| Mizuho Securities | Steven Valiquette | $222 | $201.11 | -5.4% | Jan 12, 2026 |
| Barclays | Glen Santangelo | $243 | $198.88 | +3.6% | Dec 8, 2025 |
| Mizuho Securities | Steven Valiquette | $210 | $190.22 | -10.5% | Nov 3, 2025 |
| Jefferies | Analyst unavailable | $220 | $190.22 | -6.2% | Nov 3, 2025 |
| Evercore ISI | Elizabeth Anderson | $220 | $191.29 | -6.2% | Oct 31, 2025 |
| UBS | Analyst unavailable | $220 | $192.07 | -6.2% | Oct 31, 2025 |
| Robert W. Baird | Analyst unavailable | $232 | $192.36 | -1.1% | Oct 31, 2025 |
| Argus Research | Analyst unavailable | $189 | $148.1 | -19.4% | Aug 22, 2025 |
| Leerink Partners | Michael Cherny | $186 | $146.3 | -20.7% | Aug 12, 2025 |
| Jefferies | Brian Tanquilut | $150 | $157.66 | -36.1% | Aug 12, 2025 |
| Morgan Stanley | Erin Wright | $181 | $161.41 | -22.8% | Jun 13, 2025 |
| Wells Fargo | Stephen Baxter | $179 | $155.48 | -23.7% | Jun 3, 2025 |
| Argus Research | Kristina Ruggeri | $148 | $125.17 | -36.9% | Feb 4, 2025 |
| Robert W. Baird | Eric Coldwell | $140 | $112.3 | -40.3% | Sep 23, 2024 |
| Argus Research | David Toung | $125 | $112.36 | -46.7% | Sep 11, 2024 |
| Deutsche Bank | George Hill | $119 | $107.91 | -49.3% | Aug 16, 2024 |
| Evercore ISI | Elizabeth Anderson | $115 | $107.71 | -51.0% | Aug 15, 2024 |
| Morgan Stanley | Erin Wright | $119 | $106.36 | -49.3% | Aug 15, 2024 |
| Mizuho Securities | Ann Hynes | $110 | $107.39 | -53.1% | Aug 15, 2024 |
| Robert W. Baird | Eric Coldwell | $137 | $107.33 | -41.6% | Aug 15, 2024 |
| Wells Fargo | Stephen Baxter | $101 | $106.36 | -56.9% | Aug 15, 2024 |
| CFRA | Garrett Nelson | $111 | $99.01 | -52.7% | Jun 11, 2024 |
| Robert W. Baird | Eric Coldwell | $129 | $94.75 | -45.0% | May 29, 2024 |
| Argus Research | David Toung | $115 | $97.43 | -51.0% | May 15, 2024 |
| Robert W. Baird | Eric Coldwell | $128 | $102.98 | -45.4% | May 3, 2024 |
| Robert W. Baird | Eric Coldwell | $134 | $110.12 | -42.9% | Apr 5, 2024 |
| Morgan Stanley | Erin Wright | $90 | $92.99 | -61.6% | Aug 15, 2023 |
| Wolfe Research | Tim Anderson | $127 | $79.18 | -45.9% | Apr 12, 2023 |
| Robert W. Baird | Baird Baird | $94 | $78.61 | -59.9% | Feb 8, 2023 |
| Credit Suisse | Analyst unavailable | $92 | $80.14 | -60.8% | Feb 3, 2023 |
| Morgan Stanley | Analyst unavailable | $86 | $78.12 | -63.3% | Jan 6, 2023 |
| Credit Suisse | Analyst unavailable | $79 | $79.22 | -66.3% | Nov 22, 2022 |
| UBS | Analyst unavailable | $78 | $68.51 | -66.7% | Aug 29, 2022 |
| Evercore ISI | Elizabeth Anderson | $68 | $55.83 | -71.0% | May 20, 2022 |
| Deutsche Bank | George Hill | $51 | $58.27 | -78.3% | May 8, 2022 |
| Morgan Stanley | Ricky Goldwasser | $74 | $62.96 | -68.5% | Apr 16, 2022 |
| Barclays | Steve Valiquette | $63 | $53.09 | -73.1% | Jan 17, 2022 |
| UBS | Kevin Caliendo | $61 | $48.84 | -74.0% | Nov 17, 2021 |
| Cowen & Co. | Charles Rhyee | $53 | $50.28 | -77.4% | Aug 11, 2021 |
| Bank of America Securities | Michael Cherny | $56 | $49.2 | -76.1% | Aug 5, 2021 |
Track every rating change on CAH the moment it posts. Free to start.
Start free